Fidelity Investments’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Fidelity Investments’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,418	Closed	-$35.2K	–	5747
2023 Q3	$35.2K	Hold	3,418	–	–	﹤0.01%	3521
2023 Q2	$28.2K	Sell	3,418 -801	-19%	-$4.79K	﹤0.01%	3695
2023 Q1	$23.6K	Buy	4,219 +4,126	+4,437%	+$23.6K	﹤0.01%	3780
2022 Q4	$460	Buy	+93	New	+$383	﹤0.01%	4759
2022 Q3	–	Sell	-76	Closed	–	–	5540
2022 Q2	$0	Sell	76 -1,383	-95%	-$5.19K	﹤0.01%	5643
2022 Q1	$8K	Buy	+1,459	New	+$13.1K	﹤0.01%	4317
2021 Q3	–	Sell	-11	Closed	-$1K	–	5224
2021 Q2	$1K	Buy	+11	New	+$492	﹤0.01%	4138
2019 Q3	–	Sell	-350	Closed	-$17K	–	4337
2019 Q2	$17K	Hold	350	–	–	﹤0.01%	3118
2019 Q1	$20K	Hold	350	–	–	﹤0.01%	2982
2018 Q4	$22K	Sell	350 -175	-33%	-$12.4K	﹤0.01%	2879
2018 Q3	$42K	Buy	+525	New	+$38.5K	﹤0.01%	2855

Other funds holding TRHC

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity Investments's TRHC Position: Q4 2023 in Review

Fidelity Investments sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 3,418 shares — an estimated $35.2K sold.

Fidelity Investments first reported a position in TRHC in Q3 2018 and held it in 11 quarters. The position peaked at $42K in Q3 2018. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

Fidelity Investments reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Fidelity Investments sold 3,418 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $35.2K.
Fidelity Investments first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2018 and held it in 11 quarters.
Fidelity Investments's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $42K in Q3 2018.
1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.